Comparison Between Topical Mitomycin C and Cyclosporine (NCT05627947) | Clinical Trial Compass
CompletedPhase 1
Comparison Between Topical Mitomycin C and Cyclosporine
Egypt57 participantsStarted 2021-01-01
Plain-language summary
Pterygium is a disease associated with proliferation of the fibrovascular tissues of the conjunctiva into the cornea and is related to factors such as ultraviolet light exposure, chronic stimulation, inflammation, climate, and genetics.
Who can participate
Age range
45 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosis of primary pterygium
* Pterygium size \> or equal 2mm (the horizontal length of the tissue from limbus to cornea will be measured by slit lamp biomicroscopy).
* Ocular discomfort refractory to medical treatment.
* Visual loss induced by pterygium.
* Adult Egyptian population
Exclusion Criteria:
* Patients who had recurrent pterygium or allergy to topical Cyclosporine.
* Patients who had allergy from Mitomycin C.
* Pregnant women.
* Patients with uncontrollable systemic diseases such as hypertension, diabetes, or cardiovascular diseases.
* Patients with diseases of the eye surface such as conjunctivitis and keratitis.
* Patients with a history of eye surgery within the previous six months.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Post Operative recurrence of pterygium
Timeframe: from baseline to 3 months after primary pterygium surgery.